557550

Ro106-9920

A cell-permeable tetrazolopyridazine-phenylsulfoxide compound that displays anti-inflammatory properties.

• 同義詞: Ro106-9920
• 經驗公式（希爾表示法）: C₁₀H₇N₅OS
• CAS號碼: 62645-28-7
• 分子量：: 245.26
• MDL號碼: MFCD06660085
• 分類程式碼代碼: 51111800
• NACRES: NA.77

屬性

• 品質等級: 100
• 化驗: ≥95% (HPLC)
• 形狀: solid
• 製造商／商標名: Calbiochem^®
• 儲存條件: OK to freeze; desiccated; protect from light
• 顏色: white
• 溶解度: ethanol: 1 mg/mL; DMSO: 25 mg/mL
• 運輸包裝: wet ice
• 儲存溫度: −70°C
• SMILES 字串: [S](=O)(c3ccccc3)c1n[n]2nnnc2cc1
• InChI: 1S/C10H7N5OS/c16-17(8-4-2-1-3-5-8)10-7-6-9-11-13-14-15(9)12-10/h1-7H
• InChI 密鑰: JFSXSNSCPNFCDM-UHFFFAOYSA-N

描述

一般說明

A cell-permeable tetrazolopyridazine-phenylsulfoxide compound that displays anti-inflammatory properties. Acts as a highly selective, irreversible inhibitor of IκBαee ubiquitination (IC₅₀ = 2.3 µM). Also reported to prevent degradation of IκBαee in MM6 cells (complete inhibition at ~3-5 µM). Shown to block NF-κB-dependent cytokine expression in human peripheral blood mononuclear cells (PBMN) (IC₅₀ = 600-700 nM for TNF-α, IL-1β, and IL-6 inhibition). Also shown to lower circulating levels of TNFα in LPS-treated rats. Also shown to inhibit 5-lipoxygenase (89% inhibition) and EGFR kinase (63% inhibition) at higher concentrations (10 µM).

生化／生理作用

Cell permeable: yes

Primary Target
IκBαee ubiquitination

Product does not compete with ATP.

Reversible: no

Target IC₅₀: 2.3 µM against IκBαee ubiquitination

包裝

Packaged under inert gas

警告

Toxicity: Standard Handling (A)

重構

Following reconstitution, aliquot and freeze (-70°C). Stock solutions are stable for up to 3 months at -70°C.

其他說明

Swinney, D.C., et al. 2002. J. Biol. Chem.277, 23573.

法律資訊

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

安全資訊

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable